Dilip, Kinkar Viki published the artcileResearch article on to investigate, develop and evaluate pharmaceutical excipient from orange peel powder, Application In Synthesis of 72509-76-3, the main research area is orange peel powder pharmaceutical excipient.
The present study aimed to investigate, develop and evaluate pharmaceutical excipients from orange peel powder and assess its binding property in tablets by using perindopril erbumine as a modal drug. Now a day′s synthetic polymers are mostly used in the pharmaceutical industry they have many disadvantages such as harmful effects on the human body, highly costly but recently natural polymers are used as a pharmaceutical application like orange peel waste material is used as an excipient have many advantages such as nontoxic, nonirritants easily available, it is economically and biocompatible. There are two basic categories of orange: sweet orange and bitter orange. Orange peel consists of several important constituents such as limonene, citral, vitamin c, hesperidin, and pectin are used as pharmaceutical additives. Manufacturing of tablets was done by using direct compression method on lab level tablet press (CEMACH) by direct compression method. Evaluations tests performed on tablets such as Hardness, Weight variation, friability, disintegration test, etc.
International Journal of Pharmacy and Pharmaceutical Research published new progress about Body remains. 72509-76-3 belongs to class pyridine-derivatives, name is 3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, and the molecular formula is C18H19Cl2NO4, Application In Synthesis of 72509-76-3.